Papers

2

Total Citations

24

H-Index

2

About

Renkai Guo is a rising surgical oncologist whose research is reshaping the landscape of colorectal cancer treatment through the lens of robotic and minimally invasive surgery. Dr. Guo’s primary contributions center on evaluating the efficacy of robot-assisted laparoscopic techniques and advancing the frontier of Natural Orifice Specimen Extraction Surgery (NOSES). In a landmark 2023 meta-analysis, Dr. Guo systematically demonstrated that robot-assisted treatment for mid and low rectal cancer yields favorable short-term and long-term therapeutic outcomes, providing crucial evidence for the adoption of robotic platforms in complex pelvic surgery. This work has already garnered 15 citations, signaling its growing influence. Building on this foundation, Dr. Guo’s 2024 review critically examined the progress, challenges, and future potential of robot-assisted NOSES for colorectal cancer, highlighting how this approach pushes the boundaries of minimally invasive care by eliminating abdominal incisions. By synthesizing emerging data and identifying key obstacles, this review serves as a roadmap for the next generation of scarless colorectal surgery. Dr. Guo’s focused body of work is helping to define the future of precision, patient-centered surgical oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
24
Total Citations
12
Avg Citations/Paper
🏆 Most Cited Paper
Short-term and long-term efficacy in robot-assisted treatment for mid and low rectal cancer: a systematic review and meta-analysis
15 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 4
🏛 Institutions: Shanxi Medical University, Shanxi Academy of Medical Sciences

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago